Dosage of transdermal delivery systems
OwnerWolfgang Fleischerinventor
Life of this patent
Estimating the term…
Abstract
A portable device for dispensing a length of a matrix-controlled transdermal delivery system having a dose of active agent having a carriage device for supporting a first length of matrix-controlled transdermal delivery system; a unit for entering a dose amount and transposing the dose amount into a second length of the matrix-controlled transdermal delivery system; a separating device for separating the second length of matrix-controlled transdermal delivery system from the first length of matrix-controlled transdermal delivery system; and a locking mechanism that can be activated or deactivated by entering a user code.
Claims31
A portable device for dispensing a length of a matrix-controlled transdermal delivery system having a dose of active agent comprising:
- (i) a carriage device for supporting a first length of matrix-controlled transdermal delivery system;
- (ii) a unit for entering a dose amount and transposing the dose amount into a second length of the matrix-controlled transdermal delivery system;
- (iii) a separating device for separating the second length of matrix-controlled transdermal delivery system from the first length of matrix-controlled transdermal delivery system;
- and
- (iv) a locking mechanism that can be activated or deactivated by entering a user code.
A process for preparing a first length of a matrix-controlled transdermal delivery system having a dose of an active agent comprising the steps of
- (i) applying a second length of matrix-controlled transdermal delivery system comprising an active agent on a carriage means;
- (ii) deactivating a locking mechanism;
- (iii) specifying a dose;
- (iv) transposing the dose into a first length of the matrix-controlled transdermal delivery system;
- (v) separating the first length of the matrix-controlled transdermal delivery system;
- (vi) optionally packaging the first length of the matrix-controlled transdermal delivery system;
- (vii) optionally providing a delivery slip;
- and
- (viii) optionally calculating the amount of active agent contained within the matrix-controlled transdermal delivery system over a period of time.
A matrix-controlled transdermal delivery system comprising an active agent, having a length, and having markings provided at intervals of length.
Dependencies are inferred from the claim text.